The primary objective of this study is to assess the predictive value and diagnostic potential of specific interleukins (IL-10, IL-17A, IL-1β, IL-6), chemokines (CXCL), and monocyte chemoattractant protein (MCP) in predicting severe COVID-19 outcomes and mortality. This evidence concerns the gene IL1B and COVID-19.